← Leaderboards
Burton L Nabors
University Of Alabama At Birmingham
$185,610
Attributed
$185,610
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $59.8K · FY2005–07$100K$75K$50K$25K$0
'05
'06
'07
Funding mix
By agency
NIH$185,610 · 12
By mechanism
M01$185,610 · 12
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Martin M Pike$883,047
- Louis B Nabors$6,698,272
Others in their field
Top investigators on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Gregory H Reaman · National Childhood Cancer Foundation$49,046,612
- Melissa L Bondy · Stanford University$36,047,564
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
GliomaGrantComputer Retrieval Of Information On Scientific Projects DatabaseSourceUnited States National Institutes Of HealthResourcesAnticonvulsantsFundingCytochrome P450Research PersonnelInstitutionDoseMalignant GliomaRouteToxic EffectAdultRecurrenceTumorHepaticNew Approaches To Brain Tumor Therapy ConsortiumPatient Oriented ResearchAngiogenesisHuman SubjectPharmaceutical Preparations
Grant awards (16)
NABTT 0306 EMD 121974 TRIAL$50,376
M01 · FY2007 · RR · contact PI
NABTT 0401 - BAY 43-9006 FOR PATIENTS WITH GLIOMA$5,259
M01 · FY2007 · RR · contact PI
NABTT 0502$2,215
M01 · FY2007 · RR · contact PI
PS 341 IN THE TREATMENT OF RECURRENT GLIOMAS$1,107
M01 · FY2007 · RR · contact PI
NABTT2111 - BMS-247550$830
M01 · FY2007 · RR · contact PI
NABTT2111 - BMS-247550$9,165
M01 · FY2006 · RR · contact PI
NABTT 0401 - BAY 43-9006 FOR PATIENTS WITH GLIOMA$7,755
M01 · FY2006 · RR · contact PI
PS 341 IN THE TREATMENT OF RECURRENT GLIOMAS$6,580
M01 · FY2006 · RR · contact PI
NABTT 0306 EMD 121974 TRIAL$2,115
M01 · FY2006 · RR · contact PI
PS 341 IN THE TREATMENT OF RECURRENT GLIOMAS$17,487
M01 · FY2005 · RR
IL13-PE38QQR CYTOTOXIN IN RECURRENT MALIGNANT GLIOMA$14,740
M01 · FY2005 · RR
TREATMENT OF PATIENTS WITH RECURRENT GLIOMA$3,247
M01 · FY2005 · RR
NABTT 0401 - BAY 43-9006$2,748
M01 · FY2005 · RR
Safety of PS 341 in the treatment of recurrent gliomas$30,993
M01 · FY2004 · RR
Treatment of patients with recurrent glioma$27,119
M01 · FY2004 · RR
Karenitecin in the Treatment of Recurrent Glioma$3,874
M01 · FY2004 · RR